Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 191

1.

Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response.

Yan SF, Ramasamy R, Schmidt AM.

J Mol Med (Berl). 2009 Mar;87(3):235-47. doi: 10.1007/s00109-009-0439-2. Epub 2009 Feb 3. Review.

2.

Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene.

Kalea AZ, Reiniger N, Yang H, Arriero M, Schmidt AM, Hudson BI.

FASEB J. 2009 Jun;23(6):1766-74. doi: 10.1096/fj.08-117739. Epub 2009 Jan 22.

3.

Binding of S100 proteins to RAGE: an update.

Leclerc E, Fritz G, Vetter SW, Heizmann CW.

Biochim Biophys Acta. 2009 Jun;1793(6):993-1007. doi: 10.1016/j.bbamcr.2008.11.016. Epub 2008 Dec 11. Review.

4.

A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease.

Zhang Q, Ames JM, Smith RD, Baynes JW, Metz TO.

J Proteome Res. 2009 Feb;8(2):754-69. doi: 10.1021/pr800858h. Review.

5.

Up-regulation of S100P expression by non-steroidal anti-inflammatory drugs and its role in anti-tumorigenic effects.

Namba T, Homan T, Nishimura T, Mima S, Hoshino T, Mizushima T.

J Biol Chem. 2009 Feb 13;284(7):4158-67. doi: 10.1074/jbc.M806051200. Epub 2008 Dec 10.

6.

Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis.

Iłzecka J.

Acta Neurol Scand. 2009 Aug;120(2):119-22. doi: 10.1111/j.1600-0404.2008.01133.x. Epub 2008 Dec 2.

PMID:
19053950
7.

Expression of receptor for advanced glycation end products (RAGE) is related to prognosis in patients with esophageal squamous cell carcinoma.

Tateno T, Ueno S, Hiwatashi K, Matsumoto M, Okumura H, Setoyama T, Uchikado Y, Sakoda M, Kubo F, Ishigami S, Shinchi H, Natsugoe S.

Ann Surg Oncol. 2009 Feb;16(2):440-6. doi: 10.1245/s10434-008-0237-z. Epub 2008 Nov 20.

PMID:
19023628
8.

HMGB4, a novel member of the HMGB family, is preferentially expressed in the mouse testis and localizes to the basal pole of elongating spermatids.

Catena R, Escoffier E, Caron C, Khochbin S, Martianov I, Davidson I.

Biol Reprod. 2009 Feb;80(2):358-66. doi: 10.1095/biolreprod.108.070243. Epub 2008 Nov 5.

9.

Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases.

Zhang L, Bukulin M, Kojro E, Roth A, Metz VV, Fahrenholz F, Nawroth PP, Bierhaus A, Postina R.

J Biol Chem. 2008 Dec 19;283(51):35507-16. doi: 10.1074/jbc.M806948200. Epub 2008 Oct 24.

10.

Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42.

Hudson BI, Kalea AZ, Del Mar Arriero M, Harja E, Boulanger E, D'Agati V, Schmidt AM.

J Biol Chem. 2008 Dec 5;283(49):34457-68. doi: 10.1074/jbc.M801465200. Epub 2008 Oct 15.

11.

RAGE expression is up-regulated in human cerebral ischemia and pMCAO rats.

Zhai DX, Kong QF, Xu WS, Bai SS, Peng HS, Zhao K, Li GZ, Wang DD, Sun B, Wang JH, Wang GY, Li HL.

Neurosci Lett. 2008 Nov 7;445(1):117-21. doi: 10.1016/j.neulet.2008.08.077. Epub 2008 Sep 2.

PMID:
18782604
12.

Cancer cell metabolism: Warburg and beyond.

Hsu PP, Sabatini DM.

Cell. 2008 Sep 5;134(5):703-7. doi: 10.1016/j.cell.2008.08.021.

13.

RAGE ligation affects T cell activation and controls T cell differentiation.

Chen Y, Akirav EM, Chen W, Henegariu O, Moser B, Desai D, Shen JM, Webster JC, Andrews RC, Mjalli AM, Rothlein R, Schmidt AM, Clynes R, Herold KC.

J Immunol. 2008 Sep 15;181(6):4272-8.

14.

Assay validation and biological variation of serum receptor for advanced glycation end-products.

Brown LF, Fraser CG.

Ann Clin Biochem. 2008 Sep;45(Pt 5):518-9. doi: 10.1258/acb.2008.008043.

15.

Members of the S100 family bind p53 in two distinct ways.

Fernandez-Fernandez MR, Rutherford TJ, Fersht AR.

Protein Sci. 2008 Oct;17(10):1663-70. doi: 10.1110/ps.035527.108. Epub 2008 Aug 11.

16.

RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis.

Turovskaya O, Foell D, Sinha P, Vogl T, Newlin R, Nayak J, Nguyen M, Olsson A, Nawroth PP, Bierhaus A, Varki N, Kronenberg M, Freeze HH, Srikrishna G.

Carcinogenesis. 2008 Oct;29(10):2035-43. doi: 10.1093/carcin/bgn188. Epub 2008 Aug 9.

17.

Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE).

Xie J, Reverdatto S, Frolov A, Hoffmann R, Burz DS, Shekhtman A.

J Biol Chem. 2008 Oct 3;283(40):27255-69. doi: 10.1074/jbc.M801622200. Epub 2008 Jul 30.

18.

Receptor for advanced glycation end-products (RAGE) modulates neutrophil adhesion and migration on glycoxidated extracellular matrix.

Touré F, Zahm JM, Garnotel R, Lambert E, Bonnet N, Schmidt AM, Vitry F, Chanard J, Gillery P, Rieu P.

Biochem J. 2008 Dec 1;416(2):255-61. doi: 10.1042/BJ20080054.

PMID:
18643777
19.

Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15.

Wolf R, Howard OM, Dong HF, Voscopoulos C, Boeshans K, Winston J, Divi R, Gunsior M, Goldsmith P, Ahvazi B, Chavakis T, Oppenheim JJ, Yuspa SH.

J Immunol. 2008 Jul 15;181(2):1499-506.

20.

A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10).

Raucci A, Cugusi S, Antonelli A, Barabino SM, Monti L, Bierhaus A, Reiss K, Saftig P, Bianchi ME.

FASEB J. 2008 Oct;22(10):3716-27. doi: 10.1096/fj.08-109033. Epub 2008 Jul 4.

Items per page

Supplemental Content

Write to the Help Desk